Clinical Trial Update: Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating cemiplimab in combination with the ISA101b HPV16 vaccine for adults with recurrent/metastatic HPV16 cervical cancer after progression o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Cemiplimab (Libtayo) (cemiplimab)
• ISA101b (ISA101b)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-09-19